MediWound Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the extraordinary general meeting of shareholders held by MediWound Ltd. on September 26, 2019. The report details the voting outcomes for proposals previously disclosed in a proxy statement filed on August 14, 2019.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and shareholder voting results rather than financial performance.
Material Changes and Voting Results
- Shareholder Participation: As of the record date (August 19, 2019), there were 27,178,839 ordinary shares issued and outstanding.
- Attendance: 15,709,172 shares were present in person or by proxy, representing 57.8% of outstanding shares.
- Quorum: A quorum was properly convened under the Company's Articles of Association.
- Outcome: Both proposals presented at the meeting were approved by the shareholders in accordance with the Israeli Companies Law and the Company's Articles of Association.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document serves solely to report the successful conclusion of the shareholder meeting.
Key Facts for Investor Verification
- Verify the specific content of the two proposals approved at the September 26, 2019 meeting by reviewing the proxy statement filed on August 14, 2019 (Exhibit 99.1).
- Confirm the implementation timeline for the approved proposals, as this filing only confirms their passage.
- Note that this filing contains no financial data; investors should refer to the most recent Form 20-F or quarterly reports for financial metrics.